Budesonide is not associated with increased risk of pneumonia in COPD patients

D. Sin, D. Tashkin, X. Zhang, F. Radner, U. Sjobring, A. Thoren, P. M. A. Calverley, S. Rennard (Vancouver, Canada; Los Angeles, Omaha, United States Of America; Lund, Sweden; Liverpool, United Kingdom)

Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Session: Exacerbations of COPD and bronchiectasis: aetiology and treatment
Session type: Thematic Poster Session
Number: 2352
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Sin, D. Tashkin, X. Zhang, F. Radner, U. Sjobring, A. Thoren, P. M. A. Calverley, S. Rennard (Vancouver, Canada; Los Angeles, Omaha, United States Of America; Lund, Sweden; Liverpool, United Kingdom). Budesonide is not associated with increased risk of pneumonia in COPD patients. Eur Respir J 2009; 34: Suppl. 53, 2352

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia?
Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know?
Year: 2008


Increasing risk of exacerbation and mortality associated with increasing frequency and severity of exacerbations in COPD patients: EXACOS-UK
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes
Source: Annual Congress 2011 - COPD: burden of disease, imaging and management
Year: 2011

Six months azithromycin treatment in COPD patients with high risk of further exacerbations
Source: International Congress 2017 – Management of COPD
Year: 2017


β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011

Factors associated with exacerbations in US patients with COPD
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009

The risk of hyperkalemia in COPD and asthma patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019


COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia
Source: Eur Respir J 2010; 36: 751-757
Year: 2010



Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011

Osteoporosis risk associated with chronic corticoid inhalation therapy in patients with COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations
Source: Eur Respir J, 53 (4) 1900147; 10.1183/13993003.00147-2019
Year: 2019



Comparing pneumonia incidence in COPD patients treated with or without inhaled corticosteroid
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021


Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018



Patients at risk for COPD compared to patients diagnosed with COPD
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009


Are COPD patients with pneumonia who are taking inhaled corticosteroids at higher risk of dying?
Source: Eur Respir J 2011; 37: 1-3
Year: 2011


The effect of smoking on exacerbation risk in eosinophilic patients with COPD
Source: Eur Respir J, 50 (6) 1702086; 10.1183/13993003.02086-2017
Year: 2017



The effect of smoking on exacerbation risk in eosinophilic patients with COPD
Source: Eur Respir J, 50 (6) 1701820; 10.1183/13993003.01820-2017
Year: 2017



Statin therapy and reduced risk of pneumonia in elderly patients with diabetes
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006